Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've collected your first Wegovy pen, the sharps bin is under the bathroom sink, and now you're wondering whether there's anything useful to know before you inject. There is. Small habits around injection timing, food choices and staying hydrated can meaningfully reduce side effects and help the treatment work as intended. Wegovy (semaglutide) is a prescription-only medicine reviewed by a clinician before supply, and the tips below are grounded in the NHS patient guidance on semaglutide and the clinical evidence behind the treatment. None of it replaces your prescriber or the Patient Information Leaflet that comes with your pen, but it should make the first few weeks feel a lot less uncertain.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people pick a day of the week that suits their routine and keep it. That consistency matters less for any strict biological reason and more because it anchors the pen to something predictable (a Sunday evening, a Tuesday after work) so a dose is less likely to be forgotten. If you need to shift your injection day by a day or two, ask your prescriber first rather than guessing.
Before you inject, let the pen reach room temperature if it has been in the fridge; injecting cold medicine into the skin is uncomfortable and unnecessary. The back of the fridge door tends to be the warmest part of the fridge and an easy place to keep the pen visible, though the exact window for how long it can sit at room temperature is set out in your Patient Information Leaflet, and that document is the one to follow.
Rotate injection sites every week. Using the same patch of skin repeatedly leads to localised reactions and may affect how the medicine is absorbed. The abdomen, outer thigh and upper arm all work; the only rule is not to inject into skin that is red, bruised, or otherwise irritated. A quick clean with an alcohol swab beforehand is good practice.
If you want to understand more about the injection process itself, the guide to using Wegovy on our site goes through the steps in detail, and our Wegovy tips page also pulls together practical pointers that many people find useful once they are getting started.
Nausea is the most common side effect people report, particularly in the early weeks or after a dose increase. It is rarely severe enough to stop treatment, and it tends to ease as the body adjusts, but it is worth making it as easy on yourself as possible.
Smaller, slower meals help considerably. Wegovy slows the rate at which the stomach empties, so a large meal that would previously have sat fine can feel overwhelming. Eating until you are comfortably full rather than until the plate is empty is a practical shift most people find straightforward once appetite starts to change. Fatty and very spicy foods tend to make nausea worse; the same goes for eating quickly.
Staying hydrated is underrated. The combination of reduced appetite and nausea can mean people drink less without realising it, which compounds the problem. Plain water, herbal teas and diluted drinks are helpful. Alcohol tends to increase nausea and adds calories; the NHS guidance recommends keeping intake low.
For evidence-backed strategies specifically around eating patterns while on treatment, the tips for losing weight on Wegovy page covers this in more depth, and if you are looking for guidance on tips for taking Wegovy more generally, that page addresses common questions about timing, missed doses, and managing the early weeks.
Most side effects with Wegovy are gastrointestinal and settle with time. Nausea, loose stools, constipation, burping and indigestion are listed in the NHS guidance on semaglutide as common; they do not generally require stopping treatment, but they are worth flagging to your prescriber if they are persistent or difficult to manage.
Some symptoms do need prompt medical attention. Severe, persistent stomach pain that spreads to the back, with or without vomiting, can be a sign of pancreatitis, a serious but uncommon reaction. The MHRA issued specific guidance on this in January 2026, and the advice is clear: do not wait it out; get help. Signs of a serious allergic reaction (swelling, difficulty breathing, rapid heartbeat) and significant vision changes also warrant urgent review.
You can report any unexpected side effects through the MHRA Yellow Card scheme, which helps build the UK's ongoing safety picture for these medicines. Our aftercare team is available seven days a week if you have questions about how you're getting on; contact us through the support page.
Anyone with concerns about whether Wegovy is the right fit for their situation, or who is considering it for the first time, can read more about using Wegovy for weight loss, including what realistic outcomes look like and how the medicine fits into a broader plan, before making a decision.
The practical habits that make the biggest long-term difference are the quiet ones: consistent injection timing, regular check-ins with your prescriber, honest reporting of side effects, and staying engaged with the diet and activity changes that the medicine is designed to support, not replace.
Repeat supplies through a regulated pharmacy like ours involve a clinical review before each order. That is not a formality; it is the prescriber checking that the dose is still appropriate, that side effects are manageable and that progress is being made. It is also an opportunity to raise anything that has been on your mind. Our prescribers hear questions about Wegovy every week, and there genuinely is no question too small.
Women taking an oral contraceptive pill should be aware that a separate interaction applies for tirzepatide (Mounjaro) but current evidence does not flag the same concern with semaglutide; your prescriber can confirm this for your specific situation. Pregnancy, breastfeeding and trying to conceive are all contexts in which Wegovy is not recommended, and your prescriber needs to know if those circumstances change while you are on treatment.
If you are weighing up Wegovy against the alternatives, the semaglutide overview explains how the medicine works in more detail. And if you are wondering about what happens next clinically, our clinical team page describes who reviews your case and how.
Thinking about starting? You can begin a free consultation and have your answers reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.